Food and Drug Administration
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it waits for the Food and…
-
Are Artificial Sweeteners Safe for Kids? What Parents Should Know
The American Academy of Pediatrics recommends kids ages two to 18 consume about six teaspoons of sugar per day. According to most sources, kids in…
-
New Hope’s Orchestra BioMed Set to Receive $21M from Vivasure Sale
Orchestra BioMed, based in New Hope, is set to receive as much as $21 million in cash proceeds tied to Haemonetics Corporation’s acquisition of Ireland-based…
-
West Chester-Based Verrica Gets Medication Approval in Japan, Triggering $10M Milestone Payment
The regulatory approval of Verrica Pharmaceuticals‘ Ycanth in Japan has triggered a $10 million milestone payment to the West Chester-based company by its overseas partner,…
-
Commonwealth Secures $4.1M from Pharma Company to Expand Bucks Operations
The Commonwealth has secured a $4.1 million investment from Levittown-based Apozeal Pharmaceuticals for the expansion of its Bucks County operations. The Shapiro Administration is supporting…
-
Conshohocken’s ActiveProtective Launches Tango Belt, Eyes Nationwide Expansion
Conshohocken-based ActiveProtective has launched the Tango Belt, a fall prevention device that has been approved by the Food and Drug Administration, writes John George for…
-
Personal Tragedy Led Exton’s Kensey Nash Founder to New Role as Lungpacer Medical CEO
Personal tragedy led Doug Evans, founder of Exton-based Kensey Nash, to change his business trajectory and become CEO of Vancouver-based Lungpacer Medical, writes Brian Gormley…
-
FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment
The Food and Drug Administration has rejected an application filed by Langhorne-based Savara for its new drug candidate Molbreevi as a treatment for rare lung…
-
Newtown-Based Helius Medical Technologies Issues Reverse Stock Split
Newtown-based Helius Medical Technologies initiated a 1-for-15 reverse stock split to satisfy NASDAQ’s minimum $1 per share listing requirement, writes John George for the Philadelphia…
-
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal
Paratek Pharmaceuticals of Boston has entered into a definitive agreement to buy Yardley-based Optinose in a deal worth up to $330 million, writes John George…
-
Newtown-based Helius Medical Technologies Explores ‘Strategic Alternatives’ to Boost Stockholder Value
Helius Medical Technologies, a Newtown-based medical device company, has begun exploring “strategic alternatives,” including a reverse merger and licensing deal, to enhance stockholder value, writes…
-
Malvern-Based Annovis Bio to Focus Future Development of Its Experimental Drug on Early Alzheimer’s Patients
Malvern-based Annovis Bio plans to focus on patients who have the early form of Alzheimer’s disease in the future development of its experimental treatment for…
-
Bala Cynwyd-Based Larimar Therapeutics Chosen for FDA’s START Pilot Program
The Food and Drug Administration has selected Bala Cynwyd-based Larimar Therapeutics’ lead drug candidate for its new program inspired by the Operation Warp Speed initiative,…
-
Yardley-Based Optinose’s Xhance Nasal Spray Wins FDA Nod for Chronic Rhinosinusitis
Yardley-based Optinose got the green light from the Food and Drug Administration for their flagship nasal spray Xhance, writes John George for the Philadelphia Business…
-
Optinose Awaits FDA Verdict on Expansion for Chronic Rhinosinusitis Treatment
Yardley-based Optinose, known for its drug-device product Xhance, is at a pivotal moment as it awaits a decision from the Food and Drug Administration, writes…
-
Newtown Pharma Co. Has One Township Supervisor Wishing Its Principals Were ‘Better Corporate Citizens’
Newcomer drug manufacturer KVK Tech Inc. and its occupancy of the dormant Lockheed site were considered a Newtown boon in 2015. But it didn’t take…
-
NRx in Radnor Asks Again for Approval to Use Its COVID-19 Drug, Zyesami
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19 drug…
-
Newtown Pharma Manufacturer Faces Food and Drug Administration Fraud Charges
The U.S. Attorney’s Office filed charges against KVK-Tech, Inc., a generic drug manufacturer in Newtown, reports John George for the Philadelphia Business Journal. The federal government alleges that the…
Founding Partners
Advertisement
Affiliate Partners
